We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Bevacizumab injection
Australian Public Assessment Report
Device/Product Name
Avastin
Active ingredients
Bevacizumab injection
AusPAR Date
Published
Sponsor
Submission Number
PM-2012-02716-3-4
Submission Type
Major variation (dosage)
Decision
Rejected (low dose option), Approved (changes to Product Information)